Kenneth C. Frazier
Independent DirectorMr. Kenneth C. Frazier, J.D., also known as Ken, serves as Director at Paradigm Health, Inc. He serves as Chair of the Board of Directors of Transcarent, Inc. since February 2023. He is an Independent Director at Eikon Therapeutics, Inc., since April 1, 2022. He was Independent Lead Director at Exxon Mobil Corporation since 2020. He serves as Chairman of health assurance initiatives at General Catalyst Group Management, LLC. He served as the President of Merck & Co., Inc. since May 01, 2010 until April 01, 2021 and had been its Chief Executive Officer since January 1, 2011 until June 30, 2021. He also serves as the Chief Executive Officer of Msd Sharp & Dohme Gesellschaft Mit Beschränkter Haftung. He is a Member of Board Advisors at Catalyst Partners Acquisition Corp. Mr. Frazier served as the President of Global Human Health at Merck & Co., Inc. since August 1, 2007 and also served as its Executive Vice President from November 2006 to May 1, 2010, Senior Vice President from December 1999 to November 2006 and General Counsel from December 1999 to August 1, 2007. Mr. Frazier served as Vice President and Deputy General Counsel of Merck & Co., Inc. from January 1999 to December 1999, Assistant General Counsel from January 1997 to January 1999 and Vice President of Public Affairs from April 1994 to 1996, where he was responsible for public affairs, corporate legal activities and The Merck Company Foundation. He served as Manager of MedcoHealth Solutions Inc. since April 2002. He sits on the boards of PhRMA, Weill Cornell Medicine and Catalyst. He is co-Founder and co-Chair of OneTen. He served as Vice President, General Counsel and Secretary of Astra Merck from 1992 to 1994. He was a Partner in Litigation Department of Drinker Biddle & Reath from 1978 to 1992. He had been Executive Chairman of Merck & Co., Inc. since December 1, 2011 until November 30, 2022 and had been its Director since January 1, 2011 until November 30, 2022. He has been an Independent Non-Executive Director at Exxon Mobil Corporation since May 2009. Mr. Frazier serves as a Director of Ethics Resource Center. He serves as a Board Member of Cornerstone Christian Academy, Ithaka and Legal Services of New Jersey. He serves as an Advisory Board Member of CorporateProBono. Org, Metropolitan Corporate Counsel, National Legal Aid and Defender Association, The Rand Institute for Civil Justice, Mr. Frazier is co-Chair of the Legal Services Corporation's Leaders Council. Seton Hall University Health Law & Policy Center and University of Pennsylvania Law & Economics Center. Mr. Frazier also is a Member of the American Academy of Arts and Sciences, the American Philosophical Society, The Business Council and the Council of the American Law Institute. Mr. Frazier served as a Director of MedcoHealth Solutions Inc. He is a Member of Council of the American Law Institute, American Bar Association, American Corporate Counsel Association, Association of General Counsel, Council on Foreign Relations and Pennsylvania Bar Association. His Bar Admissions include: Supreme Court of the United States since 2002; Pennsylvania State Bar since 1978 and U. S. District Court for the Eastern District of Pennsylvania since 1978. He holds a JD from Harvard Law School in 1978 and a BA in Political Science from Pennsylvania State University in 1975.
Positions
- Company NameEikon Therapeutics, Inc.Stock CodeEIKNPositionIndependent DirectorColleagues
- RMRoger M. PerlmutterChairman, President & CEO
- MAMichael A. KlobucharChief Operating Officer
- RDRoy D. BaynesExecutive VP & Chief Medical Officer
- RTRobert TjianCo-Founder & Member of Scientific Advisory Board
- EBEric BetzigCo-Founder & Member of Scientific Advisory Board
- RLRobert Luther HuffinesIndependent Director
